Frank Witney, CEO
Frank Witney, Pres.
Timothy C. Barabe, CFO/Exec. VP
Andrew Last, Chief Commercial Officer/Exec. VP
John F. Runkel, Jr., General Counsel/Exec. VP/Sec.
Doug Farrell, VP-Investor Rel.
Doug Farrell, Treas.
Stephen P. A. Fodor, Chmn.
Phone:
408-731-5000
Fax:
408-731-5380
Toll-Free:
888-362-2447
Address:
3420 Central Expwy.
Santa Clara, CA 95051 US
GROWTH PLANS/SPECIAL FEATURES
Affymetrix, Inc. develops, manufactures, sells and services consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix markets products for two principal applications: monitoring of gene or exon expression levels and investigation of genetic variation. Its catalogue GeneChip expression arrays are available for the study of human, rat, mouse and a range of other mammalian and model organisms. Human, mouse and rat exon analysis arrays are also available. The integrated GeneChip microarray platform includes disposable DNA probe arrays consisting of nucleic acid sequences set out in an ordered, high density pattern; certain reagents for use with the probe arrays; a scanner and other instruments used to process the probe arrays; and software to analyze and manage genomic or genetic information obtained from the probe arrays. Additionally, the company markets MyGeneChip and CustomSeq products, which enable its customers to design their own custom GeneChip expression arrays or a sequence of arrays for organisms of interest to them. The firm sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies, as well as academic research centers, government research laboratories, private foundation laboratories and clinical reference laboratories, in North America and Europe. The company also sells its products through life science supply specialists acting as authorized distributors in Latin America, India, the Middle East and Asia Pacific regions. Subsidiaries include Panomics, Inc. and USB Corporation. In November 2011, Affymetrix agreed to acquire eBioscience Holding Company, Inc., a developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Affymetrix offers its employees medical, dental and vision coverage; a 401(k) plan; life and disability insurance; a tuition assistance plan; health fitness membership discounts; a lunch program; a family resources program; domestic partner benefits; and reimbursement accounts.
FINANCIALS: Sales and profits are in thousands of dollars-add 000 to get the full
amount. Yr. 2010 note: Fiscal 2010 results were not available for all companies
at press time.
- 2010 Sales: $310,746
- 2009 Sales: $327,094
- 2008 Sales: $410,249
- 2007 Sales: $371,320
- 2006 Sales: $355,317
- 2010 Profits: ($10,233)
- 2009 Profits: ($23,909)
- 2008 Profits: ($307,919)
- 2007 Profits: $12,593
- 2006 Profits: ($13,704)
Stock Ticker: AFFX
Employees: 875
Fiscal Year Ends: 12/31